TriSalus Life Sciences (TLSI) Gross Margin (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Gross Margin of 86.18% for Q1 2026, up 249.0% year-over-year from 24.69% in Q1 2025, and down 0.55% quarter-over-quarter from 86.66% in Q4 2025.
TriSalus Life Sciences (TLSI) Gross Margin (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Gross Margin history runs 5 years deep, the most recent figure standing at 86.18% for Q1 2026.
- In Q1 2026, Gross Margin rose 249.0% year-over-year to 86.18%; the TTM figure through Mar 2026 stood at 85.07% (down 53.0% YoY), while the FY2025 annual figure was 84.57%, down 148.0% from the prior year.
- Gross Margin for Q1 2026 stood at 86.18%, down from 86.66% in the prior quarter.
- The five-year high for Gross Margin was 89.83% in Q4 2023, with the low at 74.71% in Q4 2022.
- The 5-year median for Gross Margin is 84.96% (2024), against an average of 84.3%.
- The sharpest annual moves came in 2023 and 2024: Gross Margin soared 1512 bps in 2023, then tumbled 455 bps in 2024.
- TriSalus Life Sciences' Gross Margin stood at 74.71% in 2022, then rose by 20 bps to 89.83% in 2023, then retreated by 5 bps to 85.28% in 2024, then grew by 2 bps to 86.66% in 2025, then dropped by 1 bps to 86.18% in 2026.
- Business Quant data shows TLSI's Gross Margin at 86.18% in Q1 2026, 86.66% in Q4 2025, and 83.52% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.84% |
| 10 | TriSalus Life Sciences | 307.22 Mn | 260.94 Mn | 9.90 Mn | 86.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.78% |
| Mar 31, 2026 | 86.18% |
| Dec 31, 2025 | 86.66% |
| Sep 30, 2025 | 83.52% |
| Jun 30, 2025 | 83.93% |
| Mar 31, 2025 | 83.69% |
| Dec 31, 2024 | 85.28% |
| Sep 30, 2024 | 86.34% |
| Jun 30, 2024 | 87.62% |
| Mar 31, 2024 | 84.96% |
| Dec 31, 2023 | 89.83% |
| Sep 30, 2023 | 88.66% |
| Jun 30, 2023 | 83.26% |
| Mar 31, 2023 | 77.82% |
| Dec 31, 2022 | 74.71% |
| Sep 30, 2022 | 82.13% |